In vitro anti-viral activity of aqueous extracts of Kenyan Carissa edulis Prunus africana and Melia azedarach against human cytomegalovirus.

SUMMARY The aqueous extracts of three medicinal plants, Carissa edulis (Forssk.) Vahl (Apocynaceae), Prunus africana (Hook.f.) Kalkm (Rosaceae) and Melia azedarach L. (Meliaceae) have shown significant reduction in the replication of human cytomegalovirus (HCMV) in human embryonic lung (HEL) fibroblasts cells in vitro. Using the plaque inhibition assay for the determination of anti-viral activity, the HEL fibroblast cells cultured in 24 well plates were infected with 1 x 10 2 PFU 91S HCMV and treated with various concentrations of the extracts. The plaques formed were counted after 7 days incubation at 37 0 C in 5% CO2 and the percent plaques inhibited were calculated against infected untreated control. The effective concentrations inhibiting plaque formation by 50% (EC50) was found between 40 to 80 µg/ml for all the extracts. The cell cytotoxic concentrations (CC50) for each of the three extracts, by the trypan blue exclusion test, gave a safe therapeutic index. These results have demonstrated the potential anti-viral activities of the extracts of the three medicinal plants at non-cytotoxic concentrations. (Afr J Health Sci. 2007; 14:143-148)

[1]  M. Barbi,et al.  Diagnosis of congenital cytomegalovirus infection by detection of viral DNA in urine pools. , 2005, Journal of virological methods.

[2]  G. Boivin,et al.  Human Cytomegalovirus Resistance to Antiviral Drugs , 2005, Antimicrobial Agents and Chemotherapy.

[3]  Deepali Kumar,et al.  Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. , 2003, The Journal of infectious diseases.

[4]  P. Tukei,et al.  Evaluation of the HIV-1 reverse transcriptase inhibitory properties of extracts from some medicinal plants in Kenya. , 2004, African journal of health sciences.

[5]  S. Kadota,et al.  Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. , 2001, The Journal of pharmacology and experimental therapeutics.

[6]  P. Tukei,et al.  An in vitro evaluation of extracts from some medicinal plants in Kenya against herpes simplex virus. , 2001, African journal of health sciences.

[7]  W. G. Nichols,et al.  Recent advances in the therapy and prevention of CMV infections. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  T. Burnette,et al.  Acyclovir Is Phosphorylated by the Human Cytomegalovirus UL97 Protein , 1999, Antimicrobial Agents and Chemotherapy.

[9]  A. Erice Resistance of Human Cytomegalovirus to Antiviral Drugs , 1999, Clinical Microbiology Reviews.

[10]  D. Richman,et al.  Summary of the III International Consensus Symposium on Combined Antiviral Therapy. , 1998, Antiviral research.

[11]  M. Kurokawa,et al.  Prophylactic treatment of cytomegalovirus infection with traditional herbs. , 1996, Antiviral research.

[12]  C. Crumpacker,et al.  Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. , 1995, The Journal of infectious diseases.

[13]  D. Weisdorf,et al.  Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. , 1993, Transplantation.

[14]  R. Rubin Impact of cytomegalovirus infection on organ transplant recipients. , 1990, Reviews of infectious diseases.

[15]  J. Kokwaro Medicinal plants of East Africa. Kenya, Literature Bureau Nairobi , 1990 .

[16]  F. Gachathi Kikuyu botanical dictionary of plant names and uses. , 1989 .

[17]  C. Crumpacker Treatment of Cytomegalovirus Infections , 1989 .

[18]  J. Kokwaro Medicinal plants of East Africa , 1976 .

[19]  P. Manson-Bahr Review of Infectious Diseases , 1962, Nature.